The U.S. Food and Drug Administration has approved Gamida Cell Ltd's GMDA.O blood cancer therapy, Omisirge, the health regulator said on Monday.
https://www.nasdaq.com/articles/us-fda-approves-gamidas-blood-cancer-therapy
The U.S. Food and Drug Administration has approved Gamida Cell Ltd's GMDA.O blood cancer therapy, Omisirge, the health regulator said on Monday.
https://www.nasdaq.com/articles/us-fda-approves-gamidas-blood-cancer-therapy
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.